Intravitreal Faricimab in Patients With Refractory Macular Edema

Clinical trial NCT07093385 · COMPLETED

Trial details

NCT number: NCT07093385
Sponsor: University of Baghdad
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Age-Related Macular Degeneration

Start date: 2024-09-10
Primary completion: 2025-06-01
Enrollment: 43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.